Five Prime Therapeutics
Why Robinhood?
You can watch FPRX and buy or sell other stocks, ETFs, and their options commission-free!About FPRX
Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150.
FPRX Key Statistics
Stock Snapshot
As of today, Five Prime Therapeutics(FPRX) shares are valued at $38.00. The company's market cap stands at 1.77B, with a P/E ratio of -14.16.
Five Prime Therapeutics(FPRX) stock opened on 2026-04-01 at —. The price climbed to — and dipped to —.
The Five Prime Therapeutics(FPRX)'s current trading volume is 0, compared to an average daily volume of 1.11M.
During the past year, Five Prime Therapeutics(FPRX) stock moved between $2.64 at its lowest and $38.90 at its peak.
During the past year, Five Prime Therapeutics(FPRX) stock moved between $2.64 at its lowest and $38.90 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.